| 1972 | B.Sc., M.Sc. in Engineering, University of California, Los Angeles |
| 1975 | Master of Science in Medical Radiological Physics, Harvard University, Cambridge, Massachusetts |
| 1979 | Doctor of Science in Radiation Biology, Harvard University, Cambridge, Massachusetts |
| 1979-1980 | Postdoctoral Fellow in Radiobiology, Harvard School of Public Health |
| 1980-1984 | Research Fellow in Pathology, Harvard Medical School and Dana-Farber Cancer Institute |
| 1984-1985 | Private Investor |
| 1986 | Co-founder and Director, The Morningside Group Limited |
| | Company Directorship: |
| since 1986 | Hang Lung Group Limited, one of the largest China-focused real estate companies listed on the Hong Kong Stock Exchange |
| since 1993 | Morningside (China) Company Ltd., an investment management company which manages a portfolio of operating companies in mainland China in diverse industries including paper, building materials, machinery, media, communication, biotechnology and health care |
| since 1996 | Natural Polymer International Corporation, Richardson, Texas, a technology company which develops and manufactures biodegradable plastic substitute materials |
| The Morningside Foundation |
| since 2002 | Morningside (HBR) Limited, Publisher of the Harvard Business Review, Chinese edition |
| Bright Wealth Resources Limited, Publisher of Forbes magazine, Chinese edition |
| since 2004 | Serica Technologies, Medford, Massachusetts, a clinical development stage biotech company with a technology for soft tissue regeneration |
| | Vaccine Technologies Inc, Boston, Massachusetts and Haikou, China, developer of a Hepatitis B vaccine using a novel route of antigen presentation |
| since 2005 | Metacure, Inc, Israel and New York based company, maker of an implantable device which uses electrical signals to reduce appetite for food as treatment for obesity and diabetes |
| since 2006 | Critical Biologics Corporation, Cambridge, Massachusetts, a biotech company developing diagnostics and a biologic therapeutic for sepsis and end-stage renal disease |
| since 2007 | Stealth Peptide Inc., a biotech company developing a series of small peptides which protect the mitochondria from oxidative stress |
| Matrivax, a biotech company based in Boston, Massachusetts and Haikou, China, with novel technology for making multivalent polysaccharide vaccines |
| since 2008 | Inimex Pharmaceuticals, Vancouver, Canada, developing first-in-class drugs for infectious diseases and cancer that work by triggering the body s innate immune system without causing inflammation |
